menu search

Erasca Announces Pricing of Underwritten Offering of Common Stock

Erasca Announces Pricing of Underwritten Offering of Common Stock
SAN DIEGO, Dec. 09, 2022 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an underwritten offering of 15,384,616 shares of its common stock at a price of $6.50 per share. All of […] The post Erasca Announces Pricing of Underwritten Offering of Common Stock appeared first on ForexTV... Read More
Posted: Dec 9 2022, 12:32
Author Name: forextv
Views: 101994

Search within

Pages Search Results: